{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "18577953",
  "DateCompleted": {
    "Year": "2008",
    "Month": "10",
    "Day": "23"
  },
  "DateRevised": {
    "Year": "2016",
    "Month": "10",
    "Day": "18"
  },
  "Article": {
    "ArticleDate": [],
    "Language": [
      "rus"
    ],
    "ELocationID": [],
    "Journal": {
      "ISSN": "1997-7298",
      "JournalIssue": {
        "Volume": "108",
        "Issue": "5",
        "PubDate": {
          "Year": "2008"
        }
      },
      "Title": "Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova",
      "ISOAbbreviation": "Zh Nevrol Psikhiatr Im S S Korsakova"
    },
    "ArticleTitle": "[Remitted anxiety states: a specific variant of generalized anxiety disorder].",
    "Pagination": {
      "StartPage": "19",
      "EndPage": "24",
      "MedlinePgn": "19-24"
    },
    "Abstract": {
      "AbstractText": [
        "Two hundreds and four patients with generalized anxiety disorder (GAD) have been divided into 2 groups: 107 patients with remitted course (a main group) and 97 patients with the typical development of GAD (a comparison group). It has been shown that the main group is characterized by the lower intensity of anxiety affect and reactivity and the lesser duration of exacerbations. The remissions, when the tension of anxiety is completely absent or has a subclinical character, last from 2-3 weeks to 2-3 months. In the treatment, patients with remitted disorders prefer psychotherapy (44,9%) or combined therapy (psychotherapy and pharmacotherapy) - 38,85% of cases. Despite of some peculiarities remitted anxiety disorders should be considered as a variant of GAD thus confirming their unity."
      ]
    },
    "AuthorList": [
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Atamanov",
        "ForeName": "A A",
        "Initials": "AA"
      }
    ],
    "PublicationTypeList": [
      "Comparative Study",
      "English Abstract",
      "Journal Article"
    ]
  },
  "MedlineJournalInfo": {
    "Country": "Russia (Federation)",
    "MedlineTA": "Zh Nevrol Psikhiatr Im S S Korsakova",
    "NlmUniqueID": "9712194",
    "ISSNLinking": "1997-7298"
  },
  "ChemicalList": [
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Anti-Anxiety Agents"
    }
  ],
  "MeshHeadingList": [
    {
      "QualifierName": [],
      "DescriptorName": "Adult"
    },
    {
      "QualifierName": [
        "therapeutic use"
      ],
      "DescriptorName": "Anti-Anxiety Agents"
    },
    {
      "QualifierName": [
        "classification",
        "diagnosis",
        "therapy"
      ],
      "DescriptorName": "Anxiety"
    },
    {
      "QualifierName": [
        "classification",
        "diagnosis",
        "therapy"
      ],
      "DescriptorName": "Anxiety Disorders"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Diagnosis, Differential"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Female"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Follow-Up Studies"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Male"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Prognosis"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Psychotherapeutic Processes"
    },
    {
      "QualifierName": [
        "methods"
      ],
      "DescriptorName": "Remission Induction"
    }
  ]
}